Rare breast cancer: 933 adenoid cystic carcinomas from the national cancer data base

Annals of Surgical Oncology

Volumn 20, Issue 7, 2013, Pages 2236-2241

  Kulkarni, Nandini ^a   Pezzi, Christopher M ^a   Greif, Jon M ^b,c   Suzanne Klimberg, V ^d   Bailey, Lisa ^b,c   Korourian, Soheila ^d   Zuraek, Marlene ^e  

^a ABINGTON MEMORIAL HOSPITAL   (United States)

^b Bay Area Breast Surgeons Inc   (United States)

^c Summitt Medical Center   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADENOID CYSTIC CARCINOMA; ADULT; AGE DISTRIBUTION; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ETHNICITY; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; RARE DISEASE; SURVIVAL TIME;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, ADENOID CYSTIC; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; FEMALE; HORMONES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84878836257     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2911-z     Document Type: Article

References (22)

1. Alis H, Yigitbas H, Kapan S, Kalayci M, Kilic G, Aygun E. Multifocal adenoid cystic carcinoma of the breast: an unusual presentation. Can J Surg. 2008;51:E36-7.
2. Billroth T. Die cylindergeschwalst. Untersuchungen ueber die entwicklung der blutgefasse. Berlin: G. Reimer; 1856.
3. Geschickter CF. Diseases of the breast: diagnosis, pathology, and treatment. Philadelphia: J. B. Lippincott; 1945.
4. Ghabach B, Anderson WF, Curtis RE, Huycke MM, Lavigne JA, Dores GM. Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study. Breast Cancer Res. 2010;12:R54.
5. Marchiò C, Weigelt B, Reis-Filho JS. Adenoid cystic carcinomas of the breast and salivary glands (or "The strange case of Dr. Jekyll and Mr. Hyde" of exocrine gland carcinomas). J Clin Pathol. 2010;63:220-8.
6. Azoulay S, Laé M, Fréneaux P, et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol. 2005;18:1623-31. (Pubitemid 41670663)
7. Kreike B, van Kouwenhove M, Horlings H, et al. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res. 2007;9:R65. (Pubitemid 350187481)
8. Mastropasqua MG, Maiorano E, Pruneri G, et al. Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast. Mod Pathol. 2005;18:1277-82. (Pubitemid 41348645)
9. Crisi GM, Marconi SA, Makari-Judson G, Goulart RA. Expression of c-kit in adenoid cystic carcinoma of the breast. Am J Clin Pathol. 2005;124:733-9. (Pubitemid 41532508)
10. Albores-Saavedra J, Heard SC, McLaren B, Kamino H, Witkiewicz AK. Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast. Am J Clin Pathol. 2005;123:866-73. (Pubitemid 40740684)
11. Vranic S, Frkovic-Grazio S, Lamovec J, et al. Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification. Hum Pathol. 2010;41:1617-23.
12. Wetterskog D, Lopez-Garcia MA, Lambros MB, et al. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J Pathol. 2012:226:84-96.
13. Law YM, Quek ST, Tan PH, Wong SL. Adenoid cystic carcinoma of the breast. Singapore Med J. 2009;50:e8-11.
14. Kasagawa T, Suzuki M, Doki T, et al. Two cases of adenoid cystic carcinoma: preoperative cytological findings were useful in determining treatment strategy. Breast Cancer. 2006;13:112-6.
15. Anthony PP, James PD. Adenoid cystic carcinoma of the breast: prevalence, diagnostic criteria, and histogenesis. J Clin Pathol. 1975;28:647-55.
16. Lim SK, Kovi J, Warner OG. Adenoid cystic carcinoma of breast with metastasis: a case report and review of the literature. J Natl Med Assoc. 1979;71:329-30. (Pubitemid 9155515)
17. Hopkins GB, Tullis RH. Adenoid cystic carcinoma of the breast. Calif Med. 1972;117:9-11.
18. Wilson WB, Spell JP. Adenoid cystic carcinoma of breast: a case with recurrence and regional metastasis. Ann Surg. 1967;166:861-4.
19. Glazebrook KN, Reynolds C, Smith RL, Gimenez EI, Boughey JC. Adenoid cystic carcinoma of the breast. Am J Roentgenol. 2010;194:1391-6.
20. Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol. 2007;14:166-73. (Pubitemid 44954285)
21. Sumpio BE, Jennings TA, Merino MJ, Sullivan PD. Adenoid cystic carcinoma of the breast. Data from the Connecticut Tumor Registry and a review of the literature. Ann Surg. 1987;205:295-301. (Pubitemid 17037054)
22. Santamaria G, Velasco M, Zanón G,. Adenoid cystic carcinoma of the breast: mammographic appearance and pathologic correlation. Am J Roentgenol. 1998;171:1679-83. (Pubitemid 28531647)